PPHM

Biotech Most Active & Overbought stocks, Peregrine Pharmaceuticals, Gilead Sciences, ACADIA Pharmaceuticals, Affymax, Vanda Pharmaceuticals, MannKind Corporation

Shares of Peregrine Pharmaceuticals (NASDAQPHM) surged as much as 34 percent after the company signed an agreement with the Food and Drug Administration for Bavituximab for its late stage trial.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced the completion of an underwritten public offering of 9.2 million shares of its common stock. These include nearly 1.2 million shares sold to the full exercise of an option to purchase additional shares that were earlier granted to the underwriters.

Gilead Sciences, Inc. (NASDAQ:GILD) recently disclosed in its Global Healthcare Conference that the company has launched its Stribild tablet in the United States back in August of last year and since then the company recorded under 100 million in terms of total product sales.

Affymax, Inc. (NASDAQ:AFFY) recently disclosed that it has experienced significant operating losses since inception. The announcement was made in its Form 10 Q filed with the SEC.

Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) were raised by Lazard Capital on the basis of positive feedback on the company’s sleep disorder drug tasimelteon.

Shares of MannKind Corporation (NASDAQ:MNKD) have soared more than 30 percent since last week, after the company reported results for the first quarter.

Peregrine Pharmaceuticals (NASDAQPHM) shares rose 18.83% in last trading session and is closed at $ 1.54 while trading in range of $ 1.76 – 2.06 with average volume 1.75 million shares. PPHM price to sales ratio in past twelve months was calculated as 12.87 and price to cash ratio as 9.55. PPHM return on equity ratio is recorded as 16.36% and its return on assets is 12.91%.

Gilead Sciences, Inc. (NASDAQ:GILD) shares fell -0.99% in last trading session and is closed at $ 56.30 while trading in range of $ 55.21 – 56.78 with average volume 13.47 million shares. GILD price to sales ratio in past twelve months was calculated as 8.54 and price to cash ratio as 43.76. GILD return on equity ratio is recorded as 32.88% and its return on assets is 13.54%.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares rose 6.63% in last trading session and is closed at $ 13.27 while trading in range of $ 13.40 – 14.75 with average volume 5.11 million shares. ACAD price to sales ratio in past twelve months was calculated as 250.15 and price to cash ratio as 11.38. ACAD return on equity ratio is recorded as -38.49% and its return on assets is -29.64%.

Affymax, Inc. (NASDAQ:AFFY) shares fell -4.51% in last trading session and is closed at $ 1.33 while trading in range of $ 1.20 – 1.39 with average volume 7.11 million shares. AFFY price to sales ratio in past twelve months was calculated as 0.50 and price to cash ratio as 0.61. AFFY return on equity ratio is recorded as -221.68% and its return on assets is -78.76%.

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares rose 5.47% in last trading session and is closed at $ 6.58 while trading in range of $ 6.58 – 6.97 with average volume 392,692.00 shares.VNDA price to sales ratio in past twelve months was calculated as 6.03 and price to cash ratio as 1.77. VNDA return on equity ratio is recorded as -142.96% and its return on assets is -16.04%.

MannKind Corporation (NASDAQ:MNKD) shares is closed at $ 5.19 in last trading session while trading in range of $ 5.19 – 5.43 with average volume 5.49 million shares. MNKD price to sales ratio in past twelve months was calculated as 38614.32 and price to cash ratio as 55.14. MNKD return on assets ratio is recorded as -73.79%.